Diffusion-weighted MRI (DWI) holds potential to improve the detection and biological characterization of breast cancer. DWI is increasingly being incorporated into breast MRI protocols to address some of the shortcomings of routine clinical breast MRI. Potential benefits include improved differentiation of benign and malignant breast lesions, assessment and prediction of therapeutic efficacy, and noncontrast detection of breast cancer. The breast presents a unique imaging environment with significant physiologic and inter-subject variations, as well as specific challenges to achieving reliable high quality diffusion-weighted MR images. Technical innovations are helping to overcome many of the image quality issues that have limited widespread use of DWI for breast imaging. Advanced modeling approaches to further characterize tissue perfusion, complexity, and glandular organization may expand knowledge and yield improved diagnostic tools. Level of Evidence: 5 J. MAGN. RESON. IMAGING 2017;45:337-355 B reast MRI is a highly sensitive imaging tool for breast cancer detection and has gained clinical acceptance for a range of clinical indications, including supplemental screening for women at high risk of developing breast cancer and pre-operative evaluation of extent of newly diagnosed breast cancer. However, standard contrast-enhanced breast MRI used in general clinical practice provides only modest specificity, therefore, exposing many patients to unnecessary biopsies and limiting its clinical use and acceptance across institutions.
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Over the past decade, there has been increasing interest in the use of diffusion-weighted imaging (DWI) for oncology applications. DWI is an advanced MRI technique that can measure the mobility of water molecules diffusing in tissue, which is impacted by biophysical characteristics such as cell density, membrane integrity, and microstructure. Technical advantages of DWI include a short acquisition time (typically 2-3 min), wide availability on most commercial scanners, and no need for administration of any contrast agent. Given these advantages and the ability to measure distinct and possibly complementary biological properties to conventional dynamic contrast enhanced (DCE) MRI, DWI increasingly has been studied for breast imaging applications. Promising data from multiple single center studies demonstrate value of DWI for the detection and characterization of breast cancer. 1 
Breast DWI Basics
DWI is performed using motion-sensitizing gradients to measure the Brownian motion (or random movement) of water molecules. In vivo, the diffusion path of water molecules is impeded by the presence of cellular membranes and other obstacles, and thus is not truly random. In this way, water diffusivity in tissue is inversely correlated with the tissue cellularity and the integrity of cell membranes. DWI is most commonly performed using a spin-echo prepared sequence with an additional pair of diffusion gradient pulses on either side of the 180 8 refocusing pulse, Figure 1 , based on methods originally proposed by Stejskal and Tanner. 2 Diffusion gradients are typically applied in at least three orthogonal directions to obtain rotationally invariant measures. Multiple factors determine the sensitivity of the diffusion sequence to water motion, the primary of which is the degree of diffusion weighting, described by the b-value (unit s/mm 2 ), given by:
where c is the proton gyromagnetic ratio, G is the gradient strength, d is the gradient duration, and D is the time delay between the leading edges of the two diffusion-sensitizing gradients ( Fig. 1) . 3 Water protons that change location between the timing of the gradients will not be properly phased at the time of readout. As a result, the MR signal is reduced in intensity proportionally to the water mobility, and for free molecular diffusion this signal decay can be described by the monoexponential equation:
SðbÞ5S 0 e 2b Ã ADC (2) where S(b) is the signal intensity with diffusion weighting b, S 0 is the signal intensity without diffusion weighting, and ADC is the apparent diffusion coefficient (mm 2 /s). 3 In vivo, the diffusion process is not free and is modulated by a combination of mechanisms (diffusion, microstructural hindrances, microcirculation) that all contribute to the degree of signal attenuation. Nonetheless, in vivo signal decay remains relatively monoexponential within intermediate b value ranges with only a modified diffusivity, leading to the term " apparent" diffusion coefficient. In general, determination of ADC is performed by acquiring images at multiple b values and fitting the corresponding signal intensities to Eq. 2. In the simplest approach, ADC can be calculated directly (without fitting) from only two b-values, using: Numerous DWI studies have shown that malignant breast lesions typically exhibit decreased water diffusion, appearing brighter on diffusion-weighted images and darker on ADC maps compared with normal fibroglandular tissue (Fig. 2) . This reduced diffusion is attributed primarily to increased cell density, resulting in increased hindrance of water motion in the tortuous extracellular space and increased volume of restricted intracellular fluid. 5, 6 By comparison, adipose tissue exhibits very low diffusion rates, nearly 10-fold lower than breast fibroglandular tissue, due to restricted water mobility, 7 while simple cysts exhibit higher diffusion rates due to the relatively unrestricted microenironment.
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Standard DWI Acquisition and Challenges
Most DWI sequences use an echo planar imaging (EPI)-based readout. The EPI technique is used to achieve very fast image acquisition to minimize effects of subject motion and retain high signal-to-noise ratio (SNR). However, EPI is prone to artifacts such as ghosting, chemical shift, and distortions, particularly at higher field strengths. 8 These issues are further magnified for breast DWI due to the particular challenges of off-isocenter imaging, air-tissue interfaces, and significant fat content in the breast. Several common breast DWI artifacts are illustrated in Figure 3 .
With conventional single shot EPI, all k-space lines that form an image are acquired during a single excitation using an alternating gradient echo readout trajectory. As a result, alternate lines of k-space data must be reversed before Fourier transformation, which can introduce phase mismatch from several sources including deviation in the linear gradient course, eddy currents, or inadequate shimming. Phase mismatch can manifest as a Nyquist ghost artifact, appearing as a reduced intensity image that is shifted in the phase direction by half the FOV (Fig. 3a) . Inadequate fat suppression is a common problem in breast DWI, often related to poor shimming, and with EPI this results in detrimental chemical shift artifact that can overlay the area of interest (Fig. 3b) . Furthermore, fat suppression techniques cannot eliminate all fat signal, which can contaminate breast tissue ADC measures on a subvoxel level. 9, 10 This residual fat signal may need to be considered within advanced modeling and quantitative applications. Magnetic susceptibility differences and other sources of static field inhomogeneities cause nonlinear spatial distortions in the images due to phase error accumulation during the long EPI readout echo train (Figs. 3c,d ). Such distortions hinder direct comparison of the DWI data with anatomical images and other functional imaging maps, such as DCE MRI. Eddy-currents induced during application of the strong diffusion gradients cause additional image distortions in the direction of the applied gradients, resulting in misregistration between the different diffusion-weighted images at each slice level and inaccuracies in ADC calculation, 8 Figure 4 .
Advanced radiofrequency coil design, parallel imaging, and improved shimming techniques during acquisition can help to overcome multiple image quality challenges. Parallel imaging techniques to shorten echo train lengths have been shown to minimize susceptibility-related EPI artifacts in DWI and improve image quality, particularly at 3T. 11, 12 Alternate acquisition strategies can further improve image quality for breast DWI. For example, a twice-refocused diffusion preparation has been used as an alternative to the standard Stejskal-Tanner spin echo technique to reduce eddy current effects in breast DWI. 13 Other technical innovations to achieve high-quality breast DWI are described in the Emerging Techniques section below. Postprocessing solutions may also improve image quality of conventional DWI for breast imaging. Field mapping approaches use an additional MR acquisition to calculate magnetic field or voxel displacement maps, which can be applied to correct susceptibility-related EPI distortions. One correction method uses the symmetry of the distortions arising from opposite phase encoding polarities (e.g., anteriorposterior versus posterior-anterior) to determine the distortion field that unwarps the DWI images. This practical approach requires acquisition of an additional nondiffusionweighted image volume (b 5 0 s/mm 2 ) with reversed phase encoding polarity, which takes only seconds of additional scan time, and has recently shown potential for distortion correction in breast DWI.
14 Image registration techniques are also useful to reduce spatial misalignment between individual diffusion-weighted images due to patient motion or eddy-current-based distortions. 8 Figure  5 . Another meta-analysis of 14 studies confirmed that ADC measures are complementary to DCE MRI parameters for classifying suspicious breast lesions and can increase the accuracy of conventional breast MRI assessment. 19 More recently, Bickelhaupt et al reported that DWI may also be useful as a fast and noninvasive approach to assess the likelihood of malignancy for suspicious lesions detected on screening x-ray mammograms and reduce Compiling data from 26 breast DWI studies, Dorrius et al. 22 recently showed that sensitivity and specificity are not significantly affected by choice of b value, but suggested a maximum b value of 1000 s/mm 2 may be optimal for distinguishing benign and malignant lesions. Their analysis further confirmed that contrast agent administration does not significantly affect breast lesion ADC values for the wide range of imaging strategies included.
As the field of oncology pursues personalized and targeted approaches to therapies, accurate tumor characterization, both in terms of histologic composition and biological aggressiveness, is essential for selecting appropriate treatment. DWI reflects tissue microstructure, and emerging evidence suggests that quantitative ADC assessment may help to differentiate tumor subtypes. One would expect that lower ADCs the reported performance of ADC to distinguish among these subtypes has been variable. Overall, studies with larger cohorts from multiple institutions are needed to better determine the potential role of DWI as a reliable breast cancer biomarker that can guide therapies.
Axillary Lymph Nodes
Surgical staging of the axilla is highly accurate but confers significant rates of morbidity, including edema and parasthesia. Thus, there is interest in developing a noninvasive, imagebased method to determine the presence or absence of axillary lymph node metastases. While there are no features on DCE MRI that can distinguish malignant from benign nodes with high specificity, several studies have shown promise for the use of DWI to stage the axilla, Figure 6 . A recent metaanalysis of 13 studies with 1487 axillary lymph nodes demonstrated overall lower ADC values in metastatic compared with nonmetastatic nodes, with sensitivity and specificity of DWI to be 83% and 82%, respectively. 42 However, one study evaluating DWI for increasing specificity of conventional breast MRI for diagnosing axillary lymph nodes did not find any differences in ADC between morphologically suspicious malignant and benign reactive nodes, 43 and another study reported lymph node diameter measures to be more predictive of involvement than ADC values, 44 suggesting more investigation is needed to determine the added value of DWI to standard MR assessment of the axilla.
Monitoring and Predicting Treatment Response
DWI is also being explored for improving the ability to assess therapeutic response. Cytotoxic effects of chemotherapy including cell lysis, apoptosis, and necrosis cause alterations in cell membrane permeability and increase in extracellular space, which lead to a less restrictive environment for water to more freely diffuse. Therefore, it has been hypothesized that an increase in tumor ADC values may reflect favorable treatment response earlier than detectable changes in tumor size, Figure 7 . In support of this, several clinical studies have shown early changes in tumor ADC after the first cycle of chemotherapy to significantly differentiate responders from nonresponders. 45 Additionally, pretreatment ADC measures may hold prognostic value to help identify patients who will best respond to neoadjuvant treatments. Three large scale studies of women with locally advanced breast cancer undergoing neoadjuvant chemotherapy (n 5 519 women total) each showed low pretreatment tumor ADC values to be predictive of pathological complete response for triple-negative tumors, with more variable findings in luminal and HER2 1 subtypes. [48] [49] [50] However, there is wide variability in the current literature as to the utility of DWI to monitor breast cancer therapy, likely due to differences in study design (including treatment timings of imaging, patient characteristics, and ADC measurement approaches), and further investigation is needed to validate ADC as a predictive biomarker of therapeutic efficacy.
Noncontrast MR Screening
There may also be a role for DWI as an alternative to contrast-enhanced MRI for breast cancer screening. [51] [52] [53] [54] Early investigations showed many mammographically and clinically occult breast cancers are visible on DWI and exhibit low ADC values, 55 Figure 8 . In blinded reader studies, Yabuuchi et al demonstrated that a noncontrast MRI approach with DWI achieved a higher accuracy for breast cancer detection than mammography, 53 and Trimboli et al reported sensitivity of 76% and specificity of 90% for cancer detection on DWI. 52 More recently, McDonald et al evaluated the performance of DWI to detect mammographically occult breast cancers specifically in women with dense breasts. This study showed that DWI has the potential to identify as many as eight additional cancers over mammography per 1000 women screened, with reasonable specificity and positive predictive value (91% and 62%, respectively). 54 Technical optimizations of diffusion weighting and other imaging factors can further improve breast cancer detectability on DWI. 56, 57 This screening application is particularly timely given increasing breast density legislation raising awareness of the limitations of mammography in dense breasts. 58, 59 Moreover, there are growing health concerns related to the longterm use of gadolinium contrast agents used in conventional breast MRI. 60 To date, only a handful of studies have explored the utility of DWI for noncontrast screening, but promising preliminary data warrants further investigation.
Physiologic Variability of Breast ADC Measures
The breast is an active gland that undergoes a variety of physiologic changes over the course of a woman's lifetime that can affect appearance on imaging. During the menstrual cycle, the breast parenchyma undergoes both vascular and The resulting vascular response can produce enhancement of normal breast parenchyma, termed "background parenchymal enhancement" (BPE), that may prompt a false-positive finding on DCE MRI. 63, 64 Histologically, cyclic differences in luminal and basal myoepithelial cell layers, cellular vacuolization, and interlobular edema have been described, 65 which underlie changes in mammographic breast density 66 and screening performance among premenopausal women. 67 An early study investigating menstrual cycle effects on breast DWI reported nonstatistically significant variations in ADC (intra-subject coefficient of variation 5 5.5%) between four weekly measurements in healthy premenopausal volunteers with regular cycles. 68 Subsequent studies [69] [70] [71] [72] In summary, physiological modulations such as menopause and lactation can significantly influence ADC values in normal fibroglandular tissue, with less effects observed on tumor ADCs, which should be considered in clinical interpretations. However, the range of normal breast ADC values under all physiological variations appears to remain significantly higher than that of most malignancies and, therefore, may not compromise diagnostic performance. 
Emerging Techniques
Alternate Acquisition Strategies As the clinical utility of DWI for breast evaluation has grown more widespread and well-defined, efforts to maximize its image quality have seen a concomitant rise. While the motion-insensitivity and speed of single-shot EPI currently preserve its role as the most common readout for breast DWI, its artifacts motivate a range of alternatives.
Some techniques do not abandon but instead adapt EPI for improved speed, resolution, or quality. Readout-segmented EPI (rs-EPI) alters the conventional EPI trajectory by acquiring all phase encodes but restricting the readout acquisition in each shot as a means of limiting susceptibility artifacts, at the expense of longer scan time and some navigator-corrections. A range of breast DWI studies have used this approach successfully, [83] [84] [85] [86] Figure 9. In a related sense, reduced field-of-view (rFOV) approaches aim to reduce the required matrix size, and with it the susceptibility induced signal loss and distortion, for a given resolution by imaging only a subvolume. This approach must either suppress the surrounding regions (outer volume suppression [OVS]) or excite only the target region (inner volume excitation [IVI]). The latter approach (IVI) has found application to breast cancer in a range of studies using a two-dimensional (2D) spectral-spatial excitation. [87] [88] [89] [90] rFOV is highly applicable for breast lesion assessment where delineation of lesion borders and heterogeneity separate from the surrounding fibroglandular or adipose tissue can be challenging with conventional EPI, Figure 10 . Initial studies have shown both quantitative differences (i.e., lower ADC values) and qualitative differences (i.e., better defined border features and regional variations) between rFOV and conventional methods. Finally, simultaneous multislice approaches use a multiplexed excitation and acquisition approach to dramatically accelerate acquisitions in the slice dimension, and have been used in conjunction with rs-EPI in the breast. 85 Other pulse sequences or k-space trajectories can improve image quality. One single-shot sequence, termed turbo spin echo (TSE), fast spin echo, or rapid acquisition with relaxation enhancement, includes a series of spin echoes refocused by RF pulses rather than gradient echoes as in EPI. This approach has the advantage of removing T2*-related signal losses and susceptibility distortions, at the expense of increased T2-weighted signal loss and blurring and additional RF heating. Artifacts can also arise from phases imparted by the diffusion gradients preventing fulfillment of the CPMG condition and causing echo interference 91 ; these can be solved either by spoiling 92 or separating 93 echo pathways or modulating RF pulse phases. 94 Several studies have used variants of TSE-DWI for breast evaluation 68, [95] [96] [97] and have generally found comparable image quality to EPI with better morphologic agreement with anatomical imaging. However, the drawbacks of TSE-DWI for breast have prevented its widespread replacement of EPI, though technical developments continue. Another sequence class is steady-state free precession, in which a train of pulses maintains a steady-state magnetization with a mixed weighting of relaxation, flip angle excitation, and diffusion. This efficient 3D spin-echo sequence has advantages of image quality and spatial resolution, but also disadvantages of inter-shot phase errors from diffusion gradients that necessitate navigator-correction or other mitigating strategies. 98 A non-Fourier alternative to EPI is spatio-temporal encoding (SPEN), which involves exciting spins in a spatiotemporally sequential manner and acquiring signal in the presence of a gradient. Free from Nyquist sampling constraints, SPEN methods use dramatically higher acquisition gradients, avoiding many EPI artifacts and providing robustness to field inhomogeneities. Interaction between SPEN's imaging gradients and the diffusion-sensitizing gradients must be taken into account for ADC maps. Recently, SPEN-DWI in the breast showed negligible geometrical distortions, robustness to ghosting artifacts 101 and acceptable specific absorption rate (SAR) levels, demonstrating its potential for expanded use in clinical breast imaging.
High and Ultra-High Field Strengths
Another avenue to improve breast DWI is increasing field strength and capitalizing on the increased magnetization and associated SNR. While 1.5 Tesla (T) scanners may remain the most common platform for breast MRI, 3T scanners are increasingly prominent and are showing comparable or superior quality for the whole breast exam, including DWI. A comprehensive large-scale comparison of breast DWI between 1.5T and 3T has yet to be performed. In the ultra-high field (7T and above) regime, selected breast DWI studies have been performed with conventional EPI 102, 103 or rs-EPI. 104, 105 One rs-EPI study of 28 patients scanned at both field strengths found lower ADC values, higher resolution, equivalent SNR, and comparable diagnostic accuracy at 7T compared with 3T. 105 Whether the 7T platform will eventually be used for widespread clinical breast evaluation is yet to be seen, but initial indications are that breast DWI can successfully be performed at 7T, and the combination of high field strength and sequence innovation can improve its utility.
Advanced DWI Modeling
While the simplicity and ubiquity of the single component isotropic ADC model, as well as its applicability to cancer diagnosis, have led to its widespread application in breast DWI, there is an increasing use of advanced diffusion techniques to characterize both normal fibroglandular tissue and breast neoplasms. These approaches include additional sampling and analysis frameworks that capitalize on features such as structural anisotropy (diffusion tensor imaging, DTI), microvascularity (intravoxel incoherent motion, IVIM), and microstructural complexity (diffusion kurtosis imaging, DKI). The use of these methods is motivated by the view that additional specificity in the description of breast tissue will enable more powerful differentiation, classification, and prognostication of disease. Studies exploring these approaches for breast imaging are in early stages, ranging from assessing feasibility to preliminary data collection, and some begin to assess clinical diagnostic power. 
DTI: Anisotropy
Water diffusion within biological tissue is often anisotropic due to directionally-dependent restriction imposed by microstructural architecture. DTI extends standard DWI to characterize the orientational variability of the diffusion process, allowing assessment of diffusion directionality or anisotropy in addition to the diffusion rate (as measured by ADC). DTI requires acquisition of a greater number of diffusion gradient directions, six or more, and expresses the diffusion coefficient as a function of direction in the form of a tensor. 106 The calculated DTI tensor parameters include the eigenvalues (k 1 , k 2 , and k 3 ), their average (mean diffusivity [MD] or ADC) and associated anisotropy indices expressing variability between the eigenvalues, such as the normalized index of fractional anisotropy (FA). It has been proposed that the mammary ductal network may impose diffusion anisotropy in healthy fibroglandular tissue, with less restricted water diffusion in directions parallel to the walls of the ducts, which has been investigated by several DTI studies. 77, [107] [108] [109] [110] Malignant transformation may in turn cause blockage of the ducts by proliferating neoplastic cells and loss of structured organization, resulting in a concomitant reduction of anisotropy measures, Figure 11 . Indeed, two studies demonstrated FA to be significantly reduced in malignancies versus normal breast tissue, 111, 112 although several other DTI studies found no difference. [113] [114] [115] [116] In differentiating breast lesions, a general consensus exists across studies regarding significantly reduced diffusivity (ADC or MD) in malignant tumors versus benign lesions. However, there are conflicting results regarding the diagnostic utility of the anisotropy indices, with several studies reporting lower FA in benign lesions compared with malignant lesions 27, 112, 113, 117 and others finding no difference in FA, 111, 114, 115 warranting further investigation. One study 116 reported the eigenvalue difference (k 1 -k 3 ), another measure of anisotropy, to significantly discriminate malignancy. Figure 12 summarizes recent studies reporting DTI metrics in human breast cancers, 27,111-118 with corresponding study characteristics reported in Table 1 . The variable findings may be attributable in part to differences across studies in measurement approach, patient cohort, and lesion types. While the diagnostic value of diffusion anisotropy in breast is still under investigation, the qualitative distinction between structured native fibroglandular tissue and disordered neoplasms has been highlighted by a growing number of breast DTI studies, and continued work may refine characterization of this feature for clinical diagnostics. Aside from scalar metrics, maps of the primary eigenvector orientation suggest the ability of breast DTI to demonstrate structural organization and illustrate the mammary ductal tree, with primary eigenvectorê 1 generally directed anterior-posteriorly toward the nipple (Fig. 11) . 71, 110, 113 DTI tractography, which uses these eigenvector maps to continuously trace the three-dimensional trajectories of coherently organized media, was first introduced in the brain to enable visualization of the connectivity of neuronal pathways in vivo. 119 Efforts are underway to adapt conventional DTI fiber tracking methods for breast DTI, 120 but the feasibility of tractography for delineating the breast ductal network requires further investigation.
IVIM: Microvascularity
The hallmark feature of hypercellularity due to cell proliferation in tumors, and its restriction of water motion, underpins Figure 13 , and other studies illustrated much smaller (or negligible) perfusion fractions in fibroglandular tissue. 9, 124 This is consistent with the low blood volume of fibroglandular tissue compared with other more vascular organs; thus, the primary application of breast IVIM is in lesion characterization. A range of studies with 131 Clinical radiologic-pathologic correlation has shown inverse correlation between ADC and tumor to stromal ratio. 132 The advanced diffusion approaches addressing this complexity can be loosely categorized as using variable diffusion weighting or variable diffusion time. DKI quantifies non-Gaussianity ("kurtosis") of the water displacement distribution, which is measurable in a quadratic order expansion of the signal b-value dependence. 133 Several recent studies have shown mean diffusional kurtosis to be significantly higher in malignant compared with benign breast lesions, 126, [134] [135] [136] adding to the diagnostic accuracy of ADC alone, Figure 15 . Other approaches posit a distribution of diffusion coefficients leading to a "stretched-exponential" response, 129 which has also delivered diagnostic benefit in excess of diffusion alone. Both approaches typically require sampling higher b-value ranges than DWI, which for normal breast tissue can increase demand for SNR given its high normal diffusivity ($2 3 10 -3 mm 2 /s). Another important issue of nonGaussian diffusion quantification is biophysical specificity; unless coupled with an interpretive model (as in neuroimaging), 137, 138 the source of non-Gaussianity can be unclear.
Recent ex vivo microimaging results in fixed breast tissue showed the range of diffusivities among lobular, ductal, stromal, adipose, and cancerous components that contribute to DWI at conventional resolution 139 ; such analyses may inform upon the next iteration of advanced breast diffusion imaging.
Diffusion Time Dependence
The other control variable of diffusion contrast is the diffusion time (D, Fig. 1 ), which determines the interval of transport allotted to the spins to explore their environment. While for unrestricted Gaussian diffusion the diffusivity is time-independent, barriers in a biological matrix increasingly limit displacement as diffusion time increases. This effect can be exploited for additional contrast and, with a modeling context, microstructural quantification. 140 116 Another recent DTI study using a stimulated echo approach to achieve diffusion times up to 1 s showed potential for improving the ability to resolve diffusion anisotropy of fibroglandular tissue related to the mammary ducts, 141 where ductal lumens can range in scale up to hundreds of microns in diameter. Longer diffusion times may increase differentiation of cancer from normal tissue as well as refine understanding of breast fibroglandular tissue diffusion characteristics. While the emphasis on ductal architecture has been a useful interpretive guide thus far, the variable size and moderate volume fraction of mammary ducts suggests multiple stromal components (collagen, lobules) may also contribute. Indeed, further effort is warranted to disentangle all contributions to breast diffusion anisotropy, with proper attention to SNR, and using a wide range of diffusion encoding (strength, direction, diffusion time) may provide a broad supporting database.
Conclusions
There is rapidly growing evidence of the potential value of DWI to improve breast cancer detection and characterization. The technique is relatively easy to incorporate into clinical breast MRI protocols and provides complementary information to conventional breast MRI examinations. Furthermore, DWI may have value as an alternate MRI screening tool for detecting cancer without the need for any contrast agent. Multicenter trials are needed, several of which are currently underway through the American College of Radiology Imaging Network, 142, 143 to validate single-institution findings and to develop generalizable interpretation strategies. With technique standardization and clear interpretation guidelines, the role of DWI for clinical breast imaging is expected to grow in coming years. Advancements in DWI acquisition strategies are increasingly overcoming the technical issues inherent to standard echo planar imaging, which have heretofore somewhat limited widespread clinical implementation of DWI for breast imaging applications. Moreover, advanced encoding and analysis methods for breast diffusion MRI are helping to broaden understanding of water transport in the breast and may yield better diagnostic tools. While it remains to be seen which contrast mechanisms or workflows may be truly beneficial to current breast imaging practice, tissue features elucidated by tracking water motion remain an aggressively sought target. As innovation continues, we may expect more clinical benefits to emerge for DWI of the breast.
